Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in REPL — Replimune Group, Inc.

CIK 1167557 Greenwich, CT
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,408,286
+$26,453,753 QoQ
Shares Held
2,566,241
+904.4% QoQ
Ownership
2.72%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 199 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. REPL ranks #21 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in REPL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,408,286 2,566,241
2026-03-31 $1,954,533 255,495
2025-06-30 $113,447 12,212
2025-03-31 $129,195 13,251
2024-12-31 $185,390 15,309
2024-09-30 $304,533 27,786
2023-12-31 $150,264 17,825
2023-06-30 $262,153 11,290
2023-03-31 $197,156 11,164
2021-06-30 $587,019 15,279
2021-03-31 $605,379 19,842
2020-12-31 $1,083,612 28,404
2020-09-30 $905,307 39,327
2020-06-30 $884,386 35,589
2020-03-31 $444,173 44,551